For the TCGA, expression of two out of five genes (RNF149 and ZNF502) revealed an increase in disease burden in PC patients, their expression was associated with increasing tumor stage for RNF149 (odds ratio (OR) = 1.42 [1.12–1.79], p = 0.0034) and increasing Gleason score for ZNF502 (OR = 1.42 [1.16–1.74], p = 0.0006). Here, ZNF502 is linked to neoplasm.